首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Biochimica et biophysica acta-reviews on cancer

缩写:BBA-REV CANCER

ISSN:0304-419X

e-ISSN:1879-2561

IF/分区:11.2/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1257条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Qingya Qiu,Tingjun Zhang,Ping Song et al. Qingya Qiu et al.
The profound intratumoral heterogeneity and the highly dynamic spatiotemporal evolution of its immunosuppressive microenvironment in glioblastoma (GBM) are major factors underlying the limited efficacy of the standard-of-care treatment (SOC...
Lu Ding,Lianfeng Zhao,Mengting Zhang et al. Lu Ding et al.
While autologous chimeric antigen receptor (CAR)-T cell therapies have revolutionized the treatment of hematological malignancies, their widespread clinical application remains constrained by lengthy manufacturing cycles, prohibitive costs,...
Engeng Chen,Gaoyang Cao,Zhangfa Song Engeng Chen
Immunotherapy has reshaped the treatment landscape of colorectal cancer (CRC), with the clearest and most durable benefit established in mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H) disease. However, framing CRC ...
Shiji Cheng,Yuze Hua,Quan Liao et al. Shiji Cheng et al.
Perineural invasion (PNI) is associated with tumor progression, therapeutic resistance, and poor prognosis. However, the mechanisms driving tumor-nerve interactions remain incompletely understood. Emerging evidence suggests that macrophages...
Zhihao Wen,Zhaoyang Zeng,Wei Xiong et al. Zhihao Wen et al.
Hypusination of eukaryotic translation initiation factor 5 A (eIF5A) is a highly conserved post-translational modification. This process uniquely depends on spermidine and is catalyzed sequentially by deoxyhypusine synthase (DHPS) and deoxy...
Tao Zhang,Nian Chen,Jun Wang et al. Tao Zhang et al.
Glioblastoma (GBM) is the most aggressive type of primary brain tumor, and recurrence remains virtually inevitable despite standard treatment. The prevention of recurrence represents a critical unmet need. However, the evolutionary characte...
Chenliang Zhang,Liping Li,Ting Zhang Chenliang Zhang
Drug resistance remains a major obstacle in cancer therapy, underscoring the urgent need to identify new targets and therapeutic strategies to overcome resistance. The integrated stress response (ISR), an evolutionarily conserved mechanism ...
Alaa Ibrahim,Maha Nasr Alaa Ibrahim
Chimeric antigen receptor (CAR)-T cell immunotherapy is one of the emerging advancements in personalized treatment of cancer, whose design is based on the genetic modification of T cells to express chimeric antigen receptors (CARs) to gener...
Paromita Sarker,Shreyas S Rao Paromita Sarker
Brain-metastatic breast cancer (BMBC) is a severe complication of advanced breast cancer, affecting 15-30% of metastatic patients, particularly those with HER2-positive or triple-negative subtypes, and is associated with dismal prognosis an...
Wanxin Guo,Jingyi Lu,Zijie Liu et al. Wanxin Guo et al.
Ferroptosis is generally described as a regulated form of cell death associated with metabolic dysregulation and iron-dependent lipid peroxidation. Beyond gene expression and enzymatic activity, accumulating evidence indicates that ferropto...